6-methoxy-n-(3-sulfopropyl)quinolinium and Cytomegalovirus

6-methoxy-n-(3-sulfopropyl)quinolinium has been researched along with Cytomegalovirus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alton, EW; Carothers, AD; Davidson, H; Davidson-Smith, H; Dorin, JR; Greening, AP; Ho, LP; Innes, JA; Kallmeyer, G; McLachlan, G; Michaelis, U; Middleton, PG; Naujoks, K; Porteous, DJ; Samways, J; Seeber, S; Smith, SN; Stevenson, BJ	1

Other Studies

1 other study(ies) available for 6-methoxy-n-(3-sulfopropyl)quinolinium and Cytomegalovirus

Article	Year
Laboratory and clinical studies in support of cystic fibrosis gene therapy using pCMV-CFTR-DOTAP. Gene therapy, 1996, Volume: 3, Issue:12 Topics: Aerosols; Animals; Clinical Trials, Phase I as Topic; COS Cells; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Cytomegalovirus; Fatty Acids, Monounsaturated; Genetic Therapy; Genetic Vectors; Humans; Liposomes; Membrane Potentials; Mice; Nasal Mucosa; Pharmaceutical Vehicles; Quaternary Ammonium Compounds; Quinolinium Compounds; RNA, Messenger; Transfection	1996

Article

Year

Laboratory and clinical studies in support of cystic fibrosis gene therapy using pCMV-CFTR-DOTAP.

Gene therapy, 1996, Volume: 3, Issue:12

Topics: Aerosols; Animals; Clinical Trials, Phase I as Topic; COS Cells; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Cytomegalovirus; Fatty Acids, Monounsaturated; Genetic Therapy; Genetic Vectors; Humans; Liposomes; Membrane Potentials; Mice; Nasal Mucosa; Pharmaceutical Vehicles; Quaternary Ammonium Compounds; Quinolinium Compounds; RNA, Messenger; Transfection

1996